2000年至2013年台湾老年人多重疾病和多重用药的纵向数据。
Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013.
作者信息
Lai Shih-Wei, Liao Kuan-Fu, Lin Cheng-Li, Lin Cheng-Chieh, Lin Chih-Hsueh
机构信息
College of Medicine, China Medical University, Taichung, Taiwan.
Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
出版信息
Biomedicine (Taipei). 2020 Jun 5;10(2):1-4. doi: 10.37796/2211-8039.1013. eCollection 2020.
OBJECTIVE
The objective of the study was to evaluate the prevalences and trends of multimorbidity and polypharmacy in older adults in Taiwan.
METHODS
An observational study was performed using the 2000-2013 database of the Taiwan National Health Insurance Program (analysis in 2018). Participants ≥65 years were included in the study. Multimorbidity was defined as participants having two or more chronic diseases annually. Polypharmacy was defined as the average daily number of prescribed medications ≥5.
RESULTS
The prevalences of multimorbidity were 42.4% in 2000 and 56% in 2013. The prevalences of polypharmacy were 22.9% in 2000 and 32.1% in 2013.
CONCLUSIONS
From 2000 to 2013, multimorbidity and polypharmacy were prevalent among older adults in Taiwan. Public health efforts to intervene the primary prevention for chronic diseases should be considered in older adults.
目的
本研究的目的是评估台湾老年人中多种疾病并存和多种药物联合使用的患病率及趋势。
方法
利用台湾国民健康保险计划2000 - 2013年数据库（2018年进行分析）开展一项观察性研究。研究纳入年龄≥65岁的参与者。多种疾病并存定义为参与者每年患有两种或更多种慢性病。多种药物联合使用定义为每日处方药物平均数量≥5种。
结果
2000年多种疾病并存的患病率为42.4%，2013年为56%。2000年多种药物联合使用的患病率为22.9%，2013年为32.1%。
结论
2000年至2013年期间，台湾老年人中多种疾病并存和多种药物联合使用情况普遍。应考虑针对老年人开展公共卫生干预措施以进行慢性病的一级预防。
Zotero 插件